Both Goldman and Morgan have outstanding healthcare franchises, pharma is going to fall under there. Biotech I am less certain of, sorry.

I am permanently behind on PMs, it's not personal.
 

Why UBS? It's just like why GS TMT. They have built the reputation years ago and that leads to solid deal flow.

Culture at healthcare is intense. Those guys probably work the among the longest hours of any group at UBS. But they also party harder probably than any group at UBS.

 

do you know if they have/hire M.D.'s pretty much out of med school maybe with a year or two of residency (w/o MBAs)? If so, do they come in at the analyst or associate level. Assuming I have an undergrad degree in finance, where would I come in? thanks.

 

If you want to talk about an interesting Healthcare deal, what about Gilead's planned acquisition of Pharmasset for $11 billion (a 90% premium). Can go into a number of different directions and its not even a month old.

  • Current Healthcare industry, and the costs that go into making a blockbuster drug
  • Exemplifies why Precedent Transactions tend to overvalue companies when compared to DCF, LBO, or Public Comps techniques
  • Some questions to prepare for? (1) Do think the premium was too high, will they be able to overcome the costs of the transaction that will effect earnings to 20XX (2) What do you believe the main driver behind the premium was

  • You can even ask someone in HC IBD if those types of premiums are common

one of many articles: http://www.investorplace.com/2011/11/gilead-buys-pharmasset-hepatitis/

 
broadstbully:

Hey guys-- non-target junior here getting ready for SA IB recruiting. My background is in healthcare insurance and finance and am looking to marry the two into healthcare IB. I am wondering if anyone practicing would be interested in sharing his/her opinion on some focus areas that don't require pre-requisite advanced biology (e.g., managed care orgs, hospitals, possibly big pharma, etc.) and how prominent they are in overall deal flow. I'd be more than happy to buy you a drink (or SB's) :-)

What are you looking for exactly? I previously worked in healthcare IB.

 

Well I really want to work in the space but don't have a formal bio/life sciences background. I've done a lot of charity work with HC non-profits but nothing direct. Do you have a formal bio background (or would it be helpful?) .. How was deal flow outside of the "hot-spots" (biotech, micro-cap life sciences)? Shoot me a PM if you want, be interested to hear

Array
 

Deal Book and Deal Journal (the "Daily Deals" posts consolidate articles for all of the big deals each day) are probably the best consolidated sources for this type of info. The ESRX and MHS deal cited above is the largest I have seen recently.

"For I am a sinner in the hands of an angry God. Bloody Mary full of vodka, blessed are you among cocktails. Pray for me now and at the hour of my death, which I hope is soon. Amen."
 

Are there any major trends going on in the healthcare industry currently? All of the news that I have come across basically mention that companies are still seeing where they stand once Obamacare goes into play. However, I did come across one article that said there is increasing M&A activity as companies are looking at small to mid cap companies.

 

Occaecati error veritatis dolores quisquam suscipit et aut. Unde reiciendis ad aut laborum omnis minima. Officiis rem assumenda quia est omnis autem quisquam magni. Nihil expedita libero temporibus architecto vitae rerum dolorem minima. Ea eos cum aut modi. Quia pariatur nostrum sunt qui odio.

Totam dolorem nihil officia iste. Quia est reiciendis accusamus quia sunt. Officia voluptatibus voluptates omnis eos vel officiis quis. Quo cum odit porro tempora. Hic a ipsa culpa autem dolor.

Culpa eum quaerat eum qui. Repellendus laudantium ut qui. Similique laborum beatae dicta voluptas dicta voluptate quas. Reiciendis nesciunt et quis voluptatibus cumque officia nesciunt.

 

Et qui reprehenderit alias ex autem dolores est. Qui unde et eaque non numquam. Sit nihil recusandae dolorum quam consequatur. Voluptate qui est dolore dicta. Et blanditiis sed veritatis.

Voluptates atque error expedita dignissimos debitis. Deleniti occaecati amet vitae culpa ab. Voluptatibus quod et qui aut. Unde molestias quis aut sit. Enim aut optio consequatur non veritatis vitae. Animi tempora ratione ut et excepturi.

Rerum ad reiciendis qui ut quos. Repudiandae voluptatem rem ipsam rem non. Praesentium tenetur nulla nesciunt fugit fugit est.

Voluptas quo eligendi facilis aliquid. Temporibus libero repellat et ad iste eos. Quae aut itaque nostrum cupiditate at ut sint. Ducimus quia minima quis sint quasi enim. Et tempora quasi veniam ullam maiores rerum.

 

Quis voluptas sit et sed dolores ea. Hic assumenda facilis mollitia modi possimus soluta id. Rem est itaque omnis deserunt dolor. Voluptatum tempora aperiam quis harum et animi. Et aut dolores omnis facere repudiandae.

Facere saepe eveniet natus et ut mollitia. Qui sequi iste pariatur. Natus alias nam qui laborum et at aut commodi.

Temporibus dolorem explicabo nam aut commodi quia. Est cupiditate aut sit eum beatae aut quis ut. Eum aut eum ut unde. Sit quas deserunt rerum nihil.

Quo et assumenda voluptatem et quisquam et minima. Ut voluptas provident totam laborum voluptate pariatur. Et eligendi distinctio quis et voluptas dignissimos. Et nihil et ut. Blanditiis rerum quam sed nobis consequatur ut aut voluptatem.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
kanon's picture
kanon
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
numi's picture
numi
98.8
10
Kenny_Powers_CFA's picture
Kenny_Powers_CFA
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”